Literature DB >> 21895416

Genotypic heterogeneity and molecular basis of 5-flucytosine resistance among Candida dubliniensis isolates recovered from clinical specimens in Kuwait.

Suhail Ahmad1, Zia U Khan, Leena Joseph, Mohammad Asadzadeh, Ajmal Theyyathel.   

Abstract

There is a paucity of information about genotypic heterogeneity among Candida dubliniensis isolates recovered from different geographic regions. This study explored genotypic heterogeneity among 103 C. dubliniensis strains obtained over a six-year period from clinical specimens in Kuwait. Genotype assignment was based on amplification with genotype-specific primers and sequencing of rDNA. Susceptibility to 5-flucytosine was determined by means of the Etest. DNA sequencing of cytosine deaminase was performed to determine the molecular basis of resistance to 5-flucytosine. DNA sequencing of rDNA identified seven different genotypes, i.e., 68 (66%) isolates were found to belong to genotype 1, 25 to genotype 4, six to genotype 5 and one each to genotypes 6-9. Strains of genotype 2 or genotype 3 were not detected. All isolates of genotype 4 but none of other genotypes were resistant to 5-flucytosine and the resistant strains all contained S29L mutation. Isolates of all other genotypes contained wild-type codon 29 in cytosine deaminase. A simple, PCR-RFLP-based method has been developed to facilitate rapid detection of S29L mutation in cytosine deaminase. A noteworthy observation of our study is the identification of five new genotypes of C. dubliniensis isolates, recovered from oral/respiratory specimens from patients of Middle Eastern origin. Furthermore, all 5-flucytosine resistant C. dubliniensis isolates in Kuwait belonged to genotype 4 only.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895416     DOI: 10.3109/13693786.2011.597446

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  8 in total

1.  In vitro Post-Antifungal Effect of Posaconazole and Its Impact on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates.

Authors:  Arjuna Nishantha Bandara Ellepola; Ranil Samantha Dassanayake; Ziauddin Khan
Journal:  Med Princ Pract       Date:  2019-06-28       Impact factor: 1.927

2.  Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.

Authors:  Ziauddin Khan; Suhail Ahmad; Leena Joseph; Rachel Chandy
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

3.  In vitro Impact of Limited Exposure to Subtherapeutic Concentrations of Chlorhexidine Gluconate on the Adhesion-Associated Attributes of Oral Candida Species.

Authors:  Arjuna N B Ellepola; Rachel Chandy; Zia U Khan
Journal:  Med Princ Pract       Date:  2016-04-23       Impact factor: 1.927

4.  Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait.

Authors:  Mohammad Asadzadeh; Suhail Ahmad; Noura Al-Sweih; Ziauddin Khan
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

5.  Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait.

Authors:  Mohammad Asadzadeh; Ahlam F Alanazi; Suhail Ahmad; Noura Al-Sweih; Ziauddin Khan
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

6.  Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis.

Authors:  Suhail Ahmad; Ziauddin Khan; Mohammad Asadzadeh; Ajmal Theyyathel; Rachel Chandy
Journal:  BMC Infect Dis       Date:  2012-09-25       Impact factor: 3.090

7.  Population structure and molecular genetic characterization of clinical Candida tropicalis isolates from a tertiary-care hospital in Kuwait reveal infections with unique strains.

Authors:  Khaled Al-Obaid; Mohammad Asadzadeh; Suhail Ahmad; Ziauddin Khan
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

8.  Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity.

Authors:  Suhail Ahmad; Ziauddin Khan; Noura Al-Sweih; Wadha Alfouzan; Leena Joseph; Mohammad Asadzadeh
Journal:  PLoS One       Date:  2020-10-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.